Enter assignee name

CIPO Patents = 1

Forward Citations = 173

Loading Chart...

7 inventors (with patents filed for the assignee):

Tetsuo Nakamura (8 out of 13 patents)

Shunji Mishiro (4 out of 8 patents)

Hiroaki Okamoto (4 out of 5 patents)

4. Kunio Ando (2 out of 11 patents)

5. Junichi Kishimoto (1 out of 4 patents)

6. Yoshiyuki Nishikawa (1 out of 1 patent)

7. Sachiko Goto (1 out of 1 patent)

8. Sachiko Goto (0 patent)

11 patents: Sort by Forward Citations

1. 6103485 - Non-A non-B hepatitis related nucleic acids proteins peptides antigens (2000-08-15),

2. 5856458 - Oligonucleotide primers, and their application for high-fidelity (1999-01-05),

3. 5766867 - Non-A, non-B hepatitis related nucleic acids, proteins, peptides, (1998-06-16),

4. 5576299 - Formulated medicine for treatment and prevention of opportunistic (1996-11-19),

5. 5550016 - Oligonucleotides of HCV, primers and probes therefrom, method of (1996-08-27),

6. 5428145 - Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, (1995-06-27),

7. 5427909 - Oligonucleotides and determination system of HCV genotypes (1995-06-27),

8. 5198419 - Formulated medicines for enhancing the efficacy of beta-lactam (1993-03-30),

9. 5176994 - Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein (1993-01-05),

10. 5128334 - Analgesic and anti-inflammatory medicine (1992-07-07),

11. 5077193 - Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein (1991-12-31),

Immuno Japan Inc. is a biotechnology company based in Tokyo, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing the power of immunotherapy to address various diseases, particularly in the fields of oncology and autoimmune disorders. With a commitment to advancing medical science, Immuno Japan engages in extensive research and development activities, aiming to improve patient outcomes through cutting-edge technologies and novel treatment modalities.

Profile summary based on public USPTO records.